Truist Financial Trims Integer (NYSE:ITGR) Target Price to $147.00

Integer (NYSE:ITGR - Get Free Report) had its target price decreased by Truist Financial from $150.00 to $147.00 in a note issued to investors on Friday, Benzinga reports. The firm presently has a "buy" rating on the medical equipment provider's stock. Truist Financial's price target indicates a potential upside of 16.83% from the stock's current price.

A number of other brokerages have also recently commented on ITGR. Benchmark raised their target price on Integer from $130.00 to $140.00 and gave the company a "buy" rating in a report on Monday. KeyCorp raised their price objective on shares of Integer from $139.00 to $144.00 and gave the company an "overweight" rating in a research note on Tuesday, October 15th. Citigroup upped their target price on shares of Integer from $124.00 to $130.00 and gave the stock a "neutral" rating in a research note on Tuesday, October 1st. Bank of America raised their price target on shares of Integer from $135.00 to $145.00 and gave the company a "buy" rating in a research report on Tuesday, October 1st. Finally, Oppenheimer began coverage on Integer in a research report on Tuesday, July 16th. They set an "outperform" rating and a $135.00 price objective on the stock. One analyst has rated the stock with a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $139.75.

Integer Trading Down 0.7 %

Integer stock traded down $0.94 during mid-day trading on Friday, hitting $125.82. The company's stock had a trading volume of 187,372 shares, compared to its average volume of 312,382. Integer has a 1 year low of $73.40 and a 1 year high of $133.53. The company has a current ratio of 3.29, a quick ratio of 1.96 and a debt-to-equity ratio of 0.73. The firm has a market capitalization of $4.22 billion, a PE ratio of 43.54, a price-to-earnings-growth ratio of 1.86 and a beta of 1.08. The stock's fifty day moving average is $127.58 and its two-hundred day moving average is $120.98.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings data on Thursday, October 24th. The medical equipment provider reported $1.43 EPS for the quarter, topping the consensus estimate of $1.36 by $0.07. The firm had revenue of $431.42 million for the quarter, compared to analyst estimates of $440.59 million. Integer had a net margin of 6.31% and a return on equity of 11.48%. The business's revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period in the prior year, the business posted $1.27 EPS. On average, analysts anticipate that Integer will post 5.3 EPS for the current year.

Insider Activity at Integer

In related news, Director Jean M. Hobby sold 11,960 shares of the business's stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the completion of the sale, the director now owns 2,280 shares in the company, valued at $272,824.80. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 2.00% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Integer

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. boosted its holdings in shares of Integer by 0.6% in the first quarter. Vanguard Group Inc. now owns 3,826,088 shares of the medical equipment provider's stock valued at $446,428,000 after acquiring an additional 23,382 shares during the period. Earnest Partners LLC boosted its stake in Integer by 3.2% during the 2nd quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider's stock worth $139,911,000 after purchasing an additional 37,340 shares during the period. Driehaus Capital Management LLC grew its position in Integer by 62.5% during the 2nd quarter. Driehaus Capital Management LLC now owns 353,052 shares of the medical equipment provider's stock worth $40,880,000 after purchasing an additional 135,750 shares during the last quarter. Tributary Capital Management LLC increased its stake in Integer by 0.3% in the second quarter. Tributary Capital Management LLC now owns 286,449 shares of the medical equipment provider's stock valued at $33,168,000 after purchasing an additional 772 shares during the period. Finally, Envestnet Asset Management Inc. raised its holdings in shares of Integer by 0.8% in the second quarter. Envestnet Asset Management Inc. now owns 259,830 shares of the medical equipment provider's stock valued at $30,086,000 after buying an additional 1,941 shares during the last quarter. 99.29% of the stock is owned by hedge funds and other institutional investors.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.